Reaction Details |
| Report a problem with these data |
Target | Interleukin-2 |
---|
Ligand | BDBM387270 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Inhibition of IL-2 secretion |
---|
IC50 | <100.0±n/a nM |
---|
Citation | Irlapati, NR; Deshmukh, GK; Karche, VP; Jachak, SM; Sinha, N; Palle, VP; Kamboj, RK Oxazoline and isoxazoline derivatives as CRAC modulators US Patent US10292981 Publication Date 5/21/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Interleukin-2 |
---|
Name: | Interleukin-2 |
Synonyms: | IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF |
Type: | Enzyme |
Mol. Mass.: | 17630.05 |
Organism: | Homo sapiens (Human) |
Description: | P60568 |
Residue: | 153 |
Sequence: | MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRML
TFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSE
TTFMCEYADETATIVEFLNRWITFCQSIISTLT
|
|
|
BDBM387270 |
---|
n/a |
---|
Name | BDBM387270 |
Synonyms: | 2,6- Difluoro-N-(5-(2- methyl-5-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2- yl)phenyl)pyrazin- 2-yl)benzamide | US10292981, Example 87 |
Type | Small organic molecule |
Emp. Form. | C21H15F2N5O3 |
Mol. Mass. | 423.3723 |
SMILES | Cc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)-c1nn(C)c(=O)o1 |
Structure |
|